(Q39509888)

12 September 2017

title

Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus (English)

1 reference

12 September 2017

1 reference

1 reference

1 reference

1 reference

4

David T Curiel

1 reference

12 September 2017

Daniel T Rein

1

1 reference

12 September 2017

Anne Volkmer

2

1 reference

12 September 2017

Ines M Beyer

3

1 reference

12 September 2017

Wolfgang Janni

5

1 reference

12 September 2017

Anca Dragoi

6

1 reference

12 September 2017

Alexandra P Hess

7

1 reference

12 September 2017

Nicolai Maass

8

1 reference

12 September 2017

Stephan E Baldus

9

1 reference

12 September 2017

Gerd Bauerschmitz

10

1 reference

12 September 2017

Martina Breidenbach

11

1 reference

12 September 2017

language of work or name

English

0 references

publication date

13 July 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

123

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

138-146

1 reference

12 September 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Gene transfer approaches for gynecological diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Current developments in adenovirus-based cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Adenoviruses for treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Prognostic value of P-glycoprotein and proliferative index in advanced low grade serous ovarian carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Ovarian cancer: strategies for overcoming resistance to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

A new targeting approach for breast cancer gene therapy using the heparanase promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Gene transfer to cervical cancer with fiber-modified adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Short-term primary culture of epithelial cells derived from human breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Reversal of drug resistance in ovarian cancer: where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2011.06.007

1 reference

12 September 2017

1 reference